Submission
Original contributions relevant to biomedical research are accepted on the understanding that the material is not considered for publication elsewhere. All papers should be submitted and will be processed electronically via Editorial System (available from BMR web site:
https://www.editorialsystem.com/jbrt).
On submission, a corresponding author will be asked to provide:
Cover letter;
Files with Manuscripts,
Tables, Figures/Photos.
All papers which have been qualified as relevant with the scope of our Journal are reviewed. Authors should not expect royalties. Paper will normally be published in order of acceptance by the Editors, although this may occasionally be changed for reasons of space, or to publish more quickly particular paper which the Editors consider of topical interest. Proofs will be sent to the corresponding author or to the first author and should be returned within one week since receipt. No new material may be inserted in the text at proof stage. It is the author’s duty to proofread proofs for errors.
Authors should very carefully consider the preparation of papers to ensure that they communicate efficiently, because it permits the reader to gain the greatest return for the time invested in reading. Thus, we are more likely to accept those that are carefully designed and conform the instruction. Otherwise, papers will be returned to the author(s) for correction.
Review process
All scientific contributions will be peer-reviewed on the criteria of originality and quality. Submitted manuscripts will be pre-evaluated by Editor-in-Chief and Statistical Editor (except for review articles), and when meeting JBRT scope and formal requirements, they will be sent to a section Editor who upon positive pre-evaluation will assign at least two reviewers. Based on the reviews achieved, Section Editor and Editor-in-Chief will make a decision on whether a manuscript will be accepted for publication, sent back to the corresponding author for revision, or rejected. Once a manuscript is sent back to the corresponding author for revision, all points of the reviews should be answered or rebuttal should be provided in the Explanation letter. The revised manuscripts will be checked by Section Editor and by the original reviewers (if necessary), and a final decision will be made on acceptance or rejection by both Section Editor and Editor-in-Chief.
Manuscript Submission
Title Page
Please use this template title page for providing the following information.
The title page should include:
The name(s) of the author(s)
A concise and informative title
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Declarations
All manuscripts must contain the following sections under the heading 'Declarations'.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
Funding (information that explains whether and by whom the research was supported)
Conflicts of interest/Competing interests (include appropriate disclosures)
Ethics approval (include appropriate approvals or waivers)
Consent to participate (include appropriate statements)
Consent for publication (include appropriate statements)
Availability of data and material (data transparency)
Code availability (software application or custom code)
Authorship form
Referring to Authorship Responsibility and Acknowledgement, Conflict of Interest and Financial Disclosure, Copyright Transfer, are required for all authors, i.e. Authorship Responsibility and Acknowledgement: Everyone who has made substantial intellectual contributions to the study on which the article is based (for example, to the research question, design, analysis, interpretation, and written description) should be an author. It is dishonest to omit mention of someone who has participated in writing the manuscript (“ghost authorship”) and unfair to omit investigator who have had important engagement with other aspects of the work. All contributors who do not meet the criteria for authorship should be listed in an Acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chairperson who provided only general support. Any financial and material support should also be acknowledged. Conflict of Interest and Financial Disclosure: Authors are responsible for disclosing financial support from the industry or other conflicts of interest that might bias the interpretation of results.
Copyright Transfer Agreement: Authors agree that papers accepted become the copyright of the
BIOMEDYCYNA POLSKA S.A., Muchoborska 6, 54-424 Wrocław, Poland and may not be published elsewhere without the Editor’s permission in writing.
A manuscript will not be published once the original, signed form has not been submitted to the Editor with the manuscript revised after positive reviews.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Ethical approval of studies and informed consent
For all manuscripts reporting data from studies involving human participants or animals, formal approval by an appropriate institutional review board or ethics committee is required and should be described in the Methods section. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations of humans, state in the Methods section the manner in which informed consent was obtained from the study participants (i.e., oral or written). Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study.
Unauthorized use and copyright agreement
Published manuscripts become the property of BIOMEDYCYNA POLSKA S.A., Muchoborska 6, 54-424 Wrocław, Poland and may not be published elsewhere without written permission. Unauthorized use of the JBRT name, logo, or any content for commercial purposes or to promote commercial goods and services (in any format, including print, video, audio, and digital) is not permitted by BIOMEDYCYNA POLSKA S.A.
Manuscripts
A manuscript in English must be single-sided, preferably in TimesNewRoman (12) with 1.5-point spacing, written using only the ISO basic Latin alphabet. The Editor reserves the right to make literary corrections and to make suggestions to improve brevity. English is the official language. The English version of the paper will be checked by Language Editor. Unclear and unintelligible version will be sent to the author(s) for correction.
Every paper should be divided under the following headings in this order: a
Title (possibly below 150 spaces), the Names(s) of the author(s) in full. In paper with more than one author, the asterisk indicates the name of the author to whom correspondence and inquiries should be addressed, otherwise the first author is considered for the correspondence. Current email address of the indicated corresponding author or the first author must be given in a footnote on the title page; the Place(s) where the work was done including the institution name, city, country if not Poland. In papers originated from several institutions the names of the authors should be marked with respective superscripts; the
Key words (up to 6 words or phrases) for the main topics of the paper; an
Abstract (up to 250 words for regular papers and reviews) summarizing briefly main results of the paper, no literature references;
List of acronyms (abbreviations) used in the text when there are many of these; an
Introduction giving essential background by saying why the research is important, how it relates to previous works and stating clearly the objectives at the end;
Materials and Methods with sufficient experimental details permitting to repeat or extend the experiments. Literature references to the methods, sources of material, company names and location (city, country) for specific instruments must be given. Describe how the data were evaluated, including selection criteria used;
Results and Discussion presented together (in one chapter). Results should be presented concisely and organized to supplement, but not repeat, data in tables and figures. Do not display the data in both tabular and graphic form. Use narrative form to present the data for which tables or figures are unnecessary. Results should be discussed by comparison with finding of other authors and by indicating the implications and consequences, not merely recapitulating the results, and it must be accomplished with concise
Conclusions;
Acknowledgements should be made to persons who do not fill the authorship criteria (see: Authorship forms). Financial and material support should be stated in
Research funding, and additional statement should be provided regarding
Conflict of interests.
References as shown below.
Abbreviations and units
Abbreviations should only be used when long or unwieldy names occur frequently, and never in the title; they should be given at the first mention of the name. Metric SI units should be used. The capital letter L should be used for liters. Avoid the use of percentages (% g/g,% w/w; Mol-%; vol-%;), ppm, ppb. Instead, the expression such as g/kg, g/L, mg/kg, mg/mL should be used. A space must be left between a number and a symbol (e.g. 50 mL not 50mL). A small x must be used as multiplication sign between numeric values (e.g. 5 × 102 g/mL). Statistics and measurements should be given in figures, except when the number begins a sentence. Chemical formulae and solutions must specify the form used. Chemical abbreviations, unless they are internationally known, Greek symbols and unusual symbols for the first time should be defined by name in the left margin. Common species names should be followed by the Latin at the first mention, with contracting it to a single letter or word for subsequent use.
Figures
Should be submitted in separate files. They should be comprehensible without reference to the text. Maximum size 20 x 28 cm. If submitting chromatograms, please have them redrawn. Lettering: typed lettering not acceptable, should not appear on the figure but in the figure legend and should be uniform between figures. Three-dimensional graphs should only be used to illustrate real 3-D relationships. Start the scale of axes and bars or columns at zero, do not interrupt them or omit missing data on them. Figures must be cited in Arabic numbers in the text. Self-explanatory legend to all figures should be provided on the last pages of the manuscript under the heading “Legends to figures”. Electronic versions of Figures submitted with the manuscript should contain a link to data, so that they can be edited.
Tables
Should be submitted in separate files. They should be as few in number and as simple as possible (like figures, they are expensive and space consuming), and include only essential data with appropriate statistical values. Each must have an Arabic number, and a self-explanatory caption.
Equations
In the text, they should be provided as A = B/(C–D), unless they are more complicated.
References
Each must be listed alphabetically at the end of the paper in the form as follows and the list should be numbered: Periodicals – names and initials of all the authors, title of the paper, abbreviated journal title as in Chemical Abstracts, year of publication, volume, inclusive page numbers (titles of papers published in Polish must be translated into English; see example below); Books – names and initials of all the authors, names of editors, year of publication, publishing company, place of publication, inclusive page numbers; Patents – the name of the application, the title, the country, patent number or application number, the year of publication. For papers published in language other than English, the original language with a note whether the paper contains English abstract should be given in parentheses at the end. The reference list should only include peer-reviewed works that are cited in the text and that have been published or accepted for publication.
References in the text must be cited by name and year in square parentheses (e.g.: one author – [Babij, 1994]; two authors – [Adamski & Campbell, 1999]; more than two authors – [Smith et al., 1994]). If more than one paper is published in the same year by the same author or group of authors use [Smith, 1994a, b].
Examples:
Article in a journal:
Słomski, B.A., Camp, L.D., Batistuta, E., Hogward, B. (2008). Determination of indole glucosinolates in broccoli sprouts.
Journal of Food Agriculture, 40(5), 131–143.
Book:
Walter, W., Aniston, K., Mila, C. (2019).
Antioxidants for everyone 3rd edition. PBD Publishing, London, UK. pp. 222-235.
Chapter in a book:
Biden, B., Gamrot, A., Laval, C. (2018). Gas chromatography. In M. Queresi, W. Bolton (Eds.),
CRC Handbook of Chromatography, CRC Press Inc., Boca Raton, Florida, USA, pp. 44–46.
For additional information on formatting of references consult APA webpage:
https://apastyle.apa.org/style-grammar-guidelines/citations/basic-principles